Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pulse Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 2 filings
- 1 insider, $199.9K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$199.9K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pulse Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Teplitsky Liane Rae | Chief Operating Officer | 4,095 | Sep 2, 2026 | 3 |
| Skinner Jon | Chief Financial Officer | – | Aug 28, 2026 | 1 |
| Duggan Robert W | Director, 10% Owner | 48,370,047 | Jun 15, 2026 | 2 |
| van den Broek Richard | Director | – | Jun 15, 2026 | 1 |
| Sainz Maria | Director | – | Jun 15, 2026 | 2 |
| Zanganeh Maky | Director | 725,395 | Jun 15, 2026 | 1 |
| Soni Manmeet Singh | Director | – | Jun 15, 2026 | 1 |
| Laviolette Paul A | Chief Executive Officer | 15,846 | May 11, 2026 | 1 |
| Uecker Darrin | Chief Technology Officer | 284,406 | Apr 3, 2026 | 1 |
| Danahy Kevin Patrick | Chief Commercial Officer | 43,298 | Feb 23, 2026 | 4 |
| Weber Steven | Principal Accounting Officer | – | Jul 16, 2025 | 0 |
| Barrett Burke Thomas | Other: Former President and CEO | 63,172 | Dec 20, 2024 | 0 |
| Levinson Mitchell E. | Chief Strategy Officer | 8,521Indirect | Sep 30, 2024 | 0 |
| Spray Shelley D | Director | – | Jun 6, 2023 | 0 |
| Gardiner Sandra A. | CFO & EVP Admin. and Finance | – | Feb 28, 2022 | 0 |
| Debuono Laureen | Director | – | Oct 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 (view filing)7:48 PM ET | Aug 26-28 | 2 days | Teplitsky Liane RaeChief Operating Officer | PPurchase | +2.07K | $48.29 | +$100.0K | New position2.07K after | 2 lots |
| Sep 2, 2026 (view filing)7:38 PM ET | Aug 31-Sep 1 | 2 days | Teplitsky Liane RaeChief Operating Officer | PPurchase | +2.02K | $49.37 | +$100.0K | +97.8%4.09K after | 2 lots |